Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 2Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 47Carcinoma, Non-Small-Cell Lung 14Neoplasm Metastasis 11Neoplasms 9Colorectal Neoplasms 8Breast Neoplasms 8Triple Negative Breast Neoplasms 7Lung Neoplasms 6Sarcoma 5Melanoma 4Esophageal Neoplasms 3Cholangiocarcinoma 3Brain Neoplasms 3Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Pancreatic Diseases 2Gastrointestinal Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1TNBC 1Solid Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Gemcitabine 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2sonidegib 1Irinotecan 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Pancreatic Diseases × 130-nm albumin-bound paclitaxel × Clear all
NCT03535727 2024-12-31

A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Completed
48 enrolled 24 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms

NCT01431794 2020-01-22

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Terminated
23 enrolled 10 charts
Gastrointestinal

Carcinoma, Pancreatic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡